#MultipleSclerosis

Gregory MSgregory_ms
2026-01-28

Clinical trial: INFLUENCE OF THERAPEUTIC FAILURE ON THE PSYCHOSOCIAL EXPERIENCE OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-28

Clinical trial: Optimal Cut-off Points of Respiratory Muscle Strength and Endurance to Discriminate Disability Status in Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-27

Clinical trial: The Relationship Between Trunk Stability, Balance, Mobility, Upper Limb Performance, and Fatigue in Minimally to Moderately Disabled People With Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-27

Clinical trial: A Phase 1b, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics of Sapu003 in Advanced mTOR-sensitive Solid Tumors (With or Without Exemestane)

clinicaltrials.gov/study/NCT07

2026-01-27

There’s nothing truly like an Occupational Therapy appointment to make you face your challenges. It’s so much easier to just feel sad and useless. #MultipleSclerosis #PwMS #venting

Gregory MSgregory_ms
2026-01-27

Clinical trial: Efficacy, safety and cost-effectiveness of B cell tailored ocrelizumab versus standard ocrelizumab in relapsing remitting multiple sclerosis (BLOOMS):
a randomized controlled trial

euclinicaltrials.eu/search-for

Gregory MSgregory_ms
2026-01-26

Clinical trial: The Effect of Different Dual-Task Conditions on Chewing Function in Individuals With Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-26

Clinical trial: A Phase IV, Prospective, Multicenter, Open-label, Mother-milk Study to Evaluate Ofatumumab Concentration in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis Receiving Ofatumumab

clinicaltrials.gov/study/NCT06

2026-01-26

Fuck! Neurologe so: "He Punk, wir müssen reden, Du musst in Langzeitbehandlung."

Ja, hurra für mich! 🫠💊

Hätte ich 2026 mal eher umgetauscht... Fuck this, ich hol mir nen Döner.

#Hauptgewinn #chronicalillness #multiplesclerosis

Gregory MSgregory_ms
2026-01-25

Clinical trial: A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Non-active Secondary Progressive Multiple Sclerosis

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: Probiotics as a Promising Adjunct: Improving Fatigue, Quality of Life, Disability, Mood and Inflammatory Markers in Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-blind, Controlled Study

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: Effects of Therapeutic Exercise and Long-term Docosahexaenoic Acid (DHA) Supplementation on Physical, Physiological, Motor, Mental, and Cognitive Variables in Patients With Multiple Sclerosis.

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: EXpain - Is Exercise an Effective Non-pharmacological Analgesic Treatment in People With Multiple Sclerosis?

clinicaltrials.gov/study/NCT07

Gregory MSgregory_ms
2026-01-25

Clinical trial: A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

clinicaltrials.gov/study/NCT05

Gregory MSgregory_ms
2026-01-25

Clinical trial: An Exploratory Clinical Study of Anti-CD20&;B-cell Maturation Antigen(BCMA) Chimeric Antigen Receptor Autologous T Cell Product (C-CAR168) in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

clinicaltrials.gov/study/NCT07

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst